Mats Wahlstrom, Director at Coherus BioSciences, Inc. (CHRS), sold 107,166 shares at $27.52 ($2.9M) on 2016-12-08, disclosed to the SEC on 2016-12-09.
Open-market sale of $2.9M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 7,393 | $203K | 6.9% |
| 2 | $27.50 | 7,393 | $203K | 6.9% |
| 3 | $27.52 | 46,190 | $1.3M | 43.1% |
| 4 | $27.52 | 46,190 | $1.3M | 43.1% |
| Total | $27.52 avg | 107,166 | $2.9M | 100% |
| Filing → |
| TLSI | BUY | 2024-11-25 | $23K | — | Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |